Home / Ricerca per Materia / Marketing authorization (MA) for veterinary medicinal products granted via the mutual recognition procedure, the decentralized procedure and the subsequent recognition procedure

Marketing authorization (MA) for veterinary medicinal products granted via the mutual recognition procedure, the decentralized procedure and the subsequent recognition procedure


Italiano|English

ProcedureProcedure

The marketing authorization (MA) for veterinary medicinal products is granted via the mutual recognition procedure and the decentralized procedure at the request of the interested party, following the assessment of the documentation on the pharmaceutical technique, safety, residues and clinical efficacy. Such procedure allows to obtain a marketing authorization in several Member States simultaneously, submitting the same dossier in all the countries concerned.

In the case of a mutual recognition procedure, the veterinary medicinal product has already been authorized in one Member State, which will act as the reference State to extend the authorization to other Member States.

In the case of a decentralized procedure, the application for a marketing authorization can be submitted simultaneously in several Member States.   

The registration dossier of a veterinary medicinal product consists of 4 parts, divided as follows:

  • PART 1 including:
    • administrative data (applications, authorizations and fees);
    • package leaflets (summary of product characteristics, package leaflet, labels); 
    • expert reports (critical reports made by a qualified expert, one for each of the three parts constituting the technical documentation of the veterinary medicinal product).
       
  • PART 2 (Quality) including:
    • pharmaceutical technique documentation relating to the quality characteristics of the veterinary medicinal product (qualitative and quantitative composition, description of the preparation method and controls on raw materials, checks during manufacture and on the finished product, stability testing, measures to prevent transmission of TSE …).

 

  • PART 3A –3B (Safety and Residues) including:
    • documentation relating to the safety characteristics of the veterinary medicinal product (basic pharmacology, toxicological studies for single and repeated administrations, reproductive toxicity, teratogenesis, mutagenesis, residual studies for the definition of the waiting time for food-producing animals, data on environmental impact…).

 

  • PART 4 (Efficacy) including:
    • documentation relating to the pre-clinical and clinical characteristics of the veterinary medicinal product (basic pharmacology, pharmacodynamics, pharmacokinetics, tolerability in the target species, clinical tests carried out with the medicinal product in question on the requested target species and according to the planned dosage...).

 

The applicant may use one of the following registration dossiers:

  • Complete dossier;
  • Generic dossier or essentially similar product;
  • Bibliographic dossier;  
  • Copy of product dossier or informed consent;
  • “hybrid” procedure.
  • Applications for limited markets
  • Applications in exceptional circumstances

Who can apply?Who can apply?

 

Interested parties, their legal representatives or delegated persons or companies in the EU or EEA. 

What do I need?What do I need?

  • Cover Letter , eApplication form (in Italian or English) completed in the relevant parts;
  • proof of the payment of the fee;   
  • technical documentation supporting the application, as reported in Annex 2 of Regulation (EU) 2019/6.

Application form and guidelinesApplication form and guidelines

How can I apply?How can I apply?

  • On line
    App on line: Portale CESP
  • Corriere Espresso
    Receiving office: Direzione Generale della sanità animale e dei farmaci veterinari - Uff.04 ex DGSA - Medicinali veterinari e dispositivi medici per uso veterinario.
    Address of the receiving office: Viale Giorgio Ribotta 5, 00144 ROMA

How long does it take?How long does it take?

MRP: 90 days

DCP: 225 days

How much does it cost?How much does it cost?

Rate: https://www.salute.gov.it/imgs/C_17_pagineAree_527_1_file.pdf

Stamp duty: A 16,00 Euro duty stamp on the application/cover letter.


Payment method

  • Through online payment via the integrated Online Payment connected with PagoPA
    Causale: Reason for payment: the name of the veterinary medicinal product and the European procedure number must be specified.

How do I know the outcome?How do I know the outcome?

  • Certified email

Outcome PublicationOutcome Publication

  • Official Gazette

Relevant lawRelevant law

  • Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC;

  • Legislative Decree No. 193 of 6 April 2006 implementing Directive 2004/28/EC (as amended) on the Community code relating to veterinary medicinal products”, Articles 12, 13, 14, 15, 16, 17, 18, 19; Chapter IV (Articles 36 to 45); Article 110;

  • Decree of the Ministry of Labour, Health and Social Politics of 5 November 2009, Annex 1;

  • Ministerial Decree of 17 December 2007 on the placement of the barcode on packages of veterinary medicinal products;
  • Ministerial Decree of 31 October 2007 transposing Directive 2006/130/EC, which implements Directive 2001/82/EC, as regards the establishment of criteria for exempting certain veterinary medicinal products intended for food-producing animals from the requirement of a veterinary prescription.


Consulta il Trovanormesalute

Contact usContact us

  • Referent Name: Stefania Dalfrà
    Address: Via G. Ribotta, 5 00144 Roma
    Telephone: 06.59946248
    Email: s.dalfra@sanita.it
  • Referent Name: Loredana Ragni
    Address: Via G. Ribotta, 5 00144 Roma
    Telephone: 06.59943741
    Email: l.ragni@sanita.it

Referent Office for Legal proceedingsReferent Office for Legal proceedings

Direzione Generale della Sanità Animale e dei Farmaci veterinari (DGSAF)
Ufficio 4 - Medicinali veterinari

FAQFAQ

Not present

App Online

Thematic SiteThematic Site

OfficeOffice


Last modified date: 16 February 2022


.